Jessica Federer is a venture capital investor at Supernode Ventures who was formerly Chief Digital Officer at Bayer AG, making her one of the first CDOs in big pharma where she led global digital transformation across pharmaceutical, consumer, and crop science divisions. She founded and leads the Women's Health Fund, a dedicated women's health fund-of-funds and co-investment vehicle, and chairs the NYSE Health of Women Investor Summit while arguing that women's health represents a major, underpriced market opportunity that can absorb tens of billions in life sciences capital.

• A strong conviction in the massive financial potential of the women's health market, positioning it as a top area for economic growth rather than just a niche interest. She underscores this by pointing to the profitability of major pharmaceutical categories like GLP1s and sharing reports on billions of dollars in sector exits.
• Advocacy for distinct scientific research that recognizes biological differences between sexes instead of treating them the same. She frequently amplifies new academic initiatives, such as specialized journals or research at Yale, that aim to correct historical data gaps in areas like longevity and disease treatment.
• Dedication to ecosystem building by connecting startups with established institutional capital. Her timeline highlights her work in launching a fund of funds and her active role in rallying investors at major industry events like the J.P. Morgan healthcare conference to mainstream the sector.
• Interest in the intersection of technology, clinical trials, and responsible healthcare delivery. She discusses the nuances of medical screenings and supports advancements in clinical research infrastructure that can accelerate scientific progress.